| 1 |
34862251 | Mechanistic study on the species differences in excretion pathway of HR011303 in human and rats. | 2021 Dec 3 |
2 |
| 2 |
31704245 | Human efflux transport of testosterone, epitestosterone and other androgen glucuronides. | 2020 Mar |
4 |
| 3 |
32090339 | Influence of MRP3 Genetics and Hepatic Expression Ontogeny for Morphine Disposition in Neonatal and Pediatric Patients. | 2020 Aug |
2 |
| 4 |
30959153 | Major glucuronide metabolites of testosterone are primarily transported by MRP2 and MRP3 in human liver, intestine and kidney. | 2019 Jul |
4 |
| 5 |
29175180 | Efflux transport of estrogen glucuronides by human MRP2, MRP3, MRP4 and BCRP. | 2018 Apr |
2 |
| 6 |
29318243 | Chemical inhibition and stable knock-down of efflux transporters leads to reduced glucuronidation of wushanicaritin in UGT1A1-overexpressing HeLa cells: the role of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins (MRPs) in the excretion of glucuronides. | 2018 Mar 1 |
1 |
| 7 |
28850245 | Selectivity in the Efflux of Glucuronides by Human Transporters: MRP4 Is Highly Active toward 4-Methylumbelliferone and 1-Naphthol Glucuronides, while MRP3 Exhibits Stereoselective Propranolol Glucuronide Transport. | 2017 Oct 2 |
3 |
| 8 |
24459177 | The roles of MRP2, MRP3, OATP1B1, and OATP1B3 in conjugated hyperbilirubinemia. | 2014 Apr |
1 |
| 9 |
23462933 | Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. | 2013 Sep |
1 |
| 10 |
22115420 | Why do metabolites circulate? | 2012 Jan |
1 |
| 11 |
22683417 | Influence of hepatic and intestinal efflux transporters and their genetic variants on the pharmacokinetics and pharmacodynamics of raloxifene in osteoporosis treatment. | 2012 Oct |
1 |
| 12 |
22982073 | Coupling of UDP-glucuronosyltransferases and multidrug resistance-associated proteins is responsible for the intestinal disposition and poor bioavailability of emodin. | 2012 Dec 15 |
2 |
| 13 |
19754365 | The role of ABC transporters in protecting cells from bilirubin toxicity. | 2009 |
1 |
| 14 |
18698235 | Functional analysis of nonsynonymous single nucleotide polymorphism type ATP-binding cassette transmembrane transporter subfamily C member 3. | 2008 Sep |
3 |
| 15 |
17300812 | Functional analysis of the polymorphism -211C>T in the regulatory region of the human ABCC3 gene. | 2007 Mar 27 |
2 |
| 16 |
17569508 | Expression of 25 human ABC transporters in the yeast Pichia pastoris and characterization of the purified ABCC3 ATPase activity. | 2007 Jul 10 |
2 |
| 17 |
15795089 | Limited modulation of the transport activity of the human multidrug resistance proteins MRP1, MRP2 and MRP3 by nicotine glucuronide metabolites. | 2005 May 16 |
1 |
| 18 |
14643890 | Multidrug resistance protein 4 (MRP4/ABCC4) mediates efflux of bimane-glutathione. | 2004 Feb |
2 |
| 19 |
14667926 | Glucuronidation as a mechanism of intrinsic drug resistance in colon cancer cells: contribution of drug transport proteins. | 2004 Jan 1 |
1 |
| 20 |
12897433 | Multidrug resistance-associated proteins: Export pumps for conjugates with glutathione, glucuronate or sulfate. | 2003 |
1 |
| 21 |
10987286 | Transport of amphipathic anions by human multidrug resistance protein 3. | 2000 Sep 1 |
1 |
| 22 |
11023036 | Recent advances in bilirubin metabolism research: the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance. | 2000 |
2 |
| 23 |
11076395 | Hepatic secretion of conjugated drugs and endogenous substances. | 2000 |
1 |
| 24 |
9500978 | Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells. | 1998 Feb 24 |
1 |
| 25 |
9679612 | [Significance of multidrug resistance in the therapy of malignant tumors]. | 1996 Dec 15 |
1 |